MSH2 and neoplasm: Clinical data and tumor specimens (n = 28) were collected from 27 LS patients who developed incident CRC during the 2–3-yearly preventive colonoscopy surveillance (23 MLH1 and 4 MSH2 carriers, 15 females and 12 males).